Search Results 61-70 of 14607 for remdesivir
The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...
hydroxychloroquine, azithromycin, remdesivir, anti-spike antibodies, and/or convalescent plasma are not excluded from the study. Participating Mayo Clinic ...
... Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. Ann Intern Med. 2022 Dec; 175 (12):1716-1727 Epub 2022 Nov 29. View PubMed; Hozayen SM ...
Kingsley R, Rohlman C, Chaudhary R, Phelan D, Kirchoff R. Cardiac Conduction Delay Associated With Remdesivir in COVID-19 Journal of Contemporary Pharmacy ...
The hypothesis is that persistent viral infection and/or overactive/chronic immune response and inflammation are underlying contributors to PASC and that ...
Coronavirus disease 2019 (COVID-19) is caused by a virus that spreads between people. Find out how to protect yourself and those close to you.
The general aim of this study is to estimate the rate of disease progression for adults who seek testing and test positive for SARS-CoV-2. The primary endpoint ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.